Innate Immune Regulation in Inflammation Resolution and Liver Regeneration in Drug-induced Liver Injury

Overview

Journal Arch Toxicol

Specialty Toxicology

Date 2024 Oct 12

PMID 39395921

Authors

Yihan Qian

Jie Zhao

Hailong Wu

Xiaoni Kong

Affiliations

Soon will be listed here.

Abstract

Drug-induced liver injury (DILI) is an acute liver injury that poses a significant threat to human health. In severe cases, it can progress into chronic DILI or even lead to liver failure. DILI is typically caused by either intrinsic hepatotoxicity or idiosyncratic metabolic or immune responses. In addition to the direct damage drugs inflict on hepatocytes, the immune responses and liver inflammation triggered by hepatocyte death can further exacerbate DILI. Initially, we briefly discussed the differences in immune cell activation based on the type of liver cell death (hepatocytes, cholangiocytes, and LSECs). We then focused on the role of various immune cells (including macrophages, monocytes, neutrophils, dendritic cells, liver sinusoidal endothelial cells, eosinophils, natural killer cells, and natural killer T cells) in both the liver injury and liver regeneration stages of DILI. This article primarily reviews the role of innate immune regulation mediated by these immune cells in resolving inflammation and promoting liver regeneration during DILI, as well as therapeutic approaches targeting these immune cells for the treatment of DILI. Finally, we discussed the activation and function of liver progenitor cells (LPCs) during APAP-induced massive hepatic necrosis and the involvement of chronic inflammation in DILI.

References

Alam R, Stafford S, Forsythe P, Harrison R, Faubion D, Grant J . RANTES is a chemotactic and activating factor for human eosinophils. J Immunol. 1993; 150(8 Pt 1):3442-8. View

Alegre F, Marti-Rodrigo A, Polo M, Ortiz-Masia D, Banuls C, Pinti M . Macrophages Modulate Hepatic Injury Involving NLRP3 Inflammasome: The Example of Efavirenz. Biomedicines. 2022; 10(1). PMC: 8772956. DOI: 10.3390/biomedicines10010109. View

Aleo M, Luo Y, Swiss R, Bonin P, Potter D, Will Y . Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump. Hepatology. 2014; 60(3):1015-22. DOI: 10.1002/hep.27206. View

Andrade R, Chalasani N, Bjornsson E, Suzuki A, Kullak-Ublick G, Watkins P . Drug-induced liver injury. Nat Rev Dis Primers. 2019; 5(1):58. DOI: 10.1038/s41572-019-0105-0. View

Antoniades C, Quaglia A, Taams L, Mitry R, Hussain M, Abeles R . Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans. Hepatology. 2012; 56(2):735-46. DOI: 10.1002/hep.25657. View

Antoniades C, Khamri W, Abeles R, Taams L, Triantafyllou E, Possamai L . Secretory leukocyte protease inhibitor: a pivotal mediator of anti-inflammatory responses in acetaminophen-induced acute liver failure. Hepatology. 2013; 59(4):1564-76. DOI: 10.1002/hep.26933. View

Arrenberg P, Halder R, Kumar V . Cross-regulation between distinct natural killer T cell subsets influences immune response to self and foreign antigens. J Cell Physiol. 2008; 218(2):246-50. PMC: 2653050. DOI: 10.1002/jcp.21597. View

Badmann A, Langsch S, Keogh A, Brunner T, Kaufmann T, Corazza N . TRAIL enhances paracetamol-induced liver sinusoidal endothelial cell death in a Bim- and Bid-dependent manner. Cell Death Dis. 2012; 3:e447. PMC: 3542621. DOI: 10.1038/cddis.2012.185. View

Banales J, Huebert R, Karlsen T, Strazzabosco M, LaRusso N, Gores G . Cholangiocyte pathobiology. Nat Rev Gastroenterol Hepatol. 2019; 16(5):269-281. PMC: 6563606. DOI: 10.1038/s41575-019-0125-y. View

10.

Bandyopadhyay K, Marrero I, Kumar V . NKT cell subsets as key participants in liver physiology and pathology. Cell Mol Immunol. 2016; 13(3):337-46. PMC: 4856801. DOI: 10.1038/cmi.2015.115. View

11.

Bernal W, Wendon J . Acute liver failure. N Engl J Med. 2013; 369(26):2525-34. DOI: 10.1056/NEJMra1208937. View

12.

Bird T, Muller M, Boulter L, Vincent D, Ridgway R, Lopez-Guadamillas E . TGFβ inhibition restores a regenerative response in acute liver injury by suppressing paracrine senescence. Sci Transl Med. 2018; 10(454). PMC: 6420144. DOI: 10.1126/scitranslmed.aan1230. View

13.

Bjornsson E, Bergmann O, Bjornsson H, Kvaran R, Olafsson S . Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology. 2013; 144(7):1419-25, 1425.e1-3. DOI: 10.1053/j.gastro.2013.02.006. View

14.

Bourdi M, Masubuchi Y, Reilly T, Amouzadeh H, Martin J, George J . Protection against acetaminophen-induced liver injury and lethality by interleukin 10: role of inducible nitric oxide synthase. Hepatology. 2002; 35(2):289-98. DOI: 10.1053/jhep.2002.30956. View

15.

Chalasani N, Bonkovsky H, Fontana R, Lee W, Stolz A, Talwalkar J . Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study. Gastroenterology. 2015; 148(7):1340-52.e7. PMC: 4446235. DOI: 10.1053/j.gastro.2015.03.006. View

16.

Chauhan A, Sheriff L, Hussain M, Webb G, Patten D, Shepherd E . The platelet receptor CLEC-2 blocks neutrophil mediated hepatic recovery in acetaminophen induced acute liver failure. Nat Commun. 2020; 11(1):1939. PMC: 7176690. DOI: 10.1038/s41467-020-15584-3. View

17.

Connolly M, Ayo D, Malhotra A, Hackman M, Bedrosian A, Ibrahim J . Dendritic cell depletion exacerbates acetaminophen hepatotoxicity. Hepatology. 2011; 54(3):959-68. PMC: 3166555. DOI: 10.1002/hep.24429. View

18.

Crome S, Lang P, Lang K, Ohashi P . Natural killer cells regulate diverse T cell responses. Trends Immunol. 2013; 34(7):342-9. DOI: 10.1016/j.it.2013.03.002. View

19.

Daly A, Aithal G, Leathart J, Swainsbury R, Dang T, Day C . Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes. Gastroenterology. 2007; 132(1):272-81. DOI: 10.1053/j.gastro.2006.11.023. View

20.

Dambach D, Watson L, Gray K, Durham S, Laskin D . Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse. Hepatology. 2002; 35(5):1093-103. DOI: 10.1053/jhep.2002.33162. View